Diagnostic Value of Transcranial Doppler Ultrasound for Evaluating Neonatal Craniocerebral Injuries
1 other identifier
observational
60
1 country
1
Brief Summary
This study aims to evaluate the diagnostic value of transcranial Doppler ultrasonography (TCD) for evaluating neonatal craniocerebral injuries.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 22, 2025
CompletedStudy Start
First participant enrolled
January 6, 2026
CompletedFirst Posted
Study publicly available on registry
January 7, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2026
January 8, 2026
January 1, 2026
12 months
December 22, 2025
January 7, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Sensitivity of transcranial Doppler ultrasound
The sensitivity of transcranial Doppler ultrasound in diagnosing brain injury will be recorded
6 months post-procedure
Study Arms (2)
Group A
High-risk neonates with confirmed risk factor.
Group B
Healthy neonates without any identified risk factor, matched to Group A for age and sex.
Interventions
Trans-cranial ultrasound will be carried out for assessment of blood flow velocity in the anterior \[ACA\] and middle cerebral arteries \[MCA\] using duplex pulsed Doppler ultrasound.
Eligibility Criteria
This prospective observational study will be carried out on 60 neonates admitted to Kafr- Elsheikh University Hospitals over a period of one year starting from approval of the Ethics Committee of Kafr- Elsheikh, Faculty of Medicine and parents of all the included patients will provide written informed consent.
You may qualify if:
- Both sexes.
- High-risk neonates with any of the following:
- Critically ill neonates.
- Neonatal sepsis.
- Neonatal encephalopathy includes hypoxic-ischemic encephalopathy.
- Respiratory distress.
- Neonatal seizures.
- Birth asphyxia.
- Signs and or symptoms of central nervous system disorders like microcephaly, macrocephaly, hypotonia, unexplained poor feeding,
- Neonates born out of traumatic/instrumental labor.
- Suspected metabolic disturbances.
- Neonates with low APGAR score (\<7).
- Neonates with low birth weight (\<2.5 kg).
You may not qualify if:
- Congenital malformations.
- Genetic metabolic diseases or other severe complications.
- Severe intrauterine infection.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kafrelsheikh University
Kafr ash Shaykh, Kafrelsheikh, 33516, Egypt
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident of Diagnostic and Intervention Radiology, Faculty of Medicine, Kafr- Elsheikh University
Study Record Dates
First Submitted
December 22, 2025
First Posted
January 7, 2026
Study Start
January 6, 2026
Primary Completion (Estimated)
December 30, 2026
Study Completion (Estimated)
December 30, 2026
Last Updated
January 8, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- After the end of study for one year.
- Access Criteria
- The data will be available upon a reasonable request from the corresponding author.
The data will be available upon a reasonable request from the corresponding author after the end of study for one year.